Company Profile
Genomic Vision is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics

News
27/07/2017
Molecular combing featured in an oral presentation on CRISPR/Cas9 gene editing at the 3rd CSHL meeting in New York
12/07/2017
The Cologne Center for Genetics (CCG), a major European core facility in genetic analyis, adopts the molecular combing technology
30/05/2017
All documents for the shareholders’ meeting of June 20, 2017 are available on Genomic Vision website (in French only)
30/05/2017
Genomic Vision declares its eligibility to the French tax regime PEA-PME for 2017/2018 (in French only)
10/05/2017
Genomic Vision announces promising preliminary results for its clinical study in cervical cancer detection
01/03/2017
2016 annual results in line with the successful execution of the new strategy in LSR market
28/10/2016
Financial information at September 30, 2016 and implementation of a flexible financing via the reserved issuance of convertible notes with warrants
20/10/2016
Genomic Vision Presents the Initial Results of the Pilot Study Undertaken with Quest Diagnostics in Spinal Muscular Atrophy (SMA) at the ASHG 2016 Annual Meeting in Vancouver or the first half of 2016
20/07/2016
Genomic Vision is accelerating its clinical trial in cervical cancer with an additional study in the Czech Republic
11/07/2016
Genomic Vision launches EasyScan, the first digital service for analyzing DNA by molecular combing
16/06/2016
The clinical trial led by Genomic Vision and Reims University Hospital presented at the Eurogin Congress
08/02/2016
Genomic Vision to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference
18/01/2016
2015 sales in line with expectations after all planned milestones with Quest Diagnostics were met
14/01/2016
Genomic Vision to demonstrate 'molecular combing' technology's ability to identify novel cancer-causing BRCA gene variants
11/01/2016
Genomic Vision Expands its Senior Management Team through a Number of Strategic Recruitments
14/12/2015
Genomic Vision and Reims University Hospital Launch Clinical Study to Establish New Screening Tool for Early Detection and Prevention of Cervical Cancer
03/12/2015
Genomic Vision signs a strategic partnership with the Imagine Institute, the largest European genetic research and care cluster
15/10/2015
GENOMIC VISION and ROUEN University Hospital launch a trial to improve genetic counseling for Infantile Spinal Muscular Atrophy in France
09/06/2015
Genomic Vision selected for the Horizon 2020 program’s ‘BeyondSeq’ project with a total grant of €6 million
15/03/2015
FYR 2014 in line with the Company's buoyant development
Total revenue from activity: €4.9 million
Operating costs under control
Solid cash position of €22.8 million
17/02/2015
Genomic Vision renews its Strategic Collaboration with Quest Diagnostics for three more years
